key: cord-1019190-hbiopq2a
authors: Gurbaxani, B. M.; Hill, A. N.; Paul, P.; Prasad, P. V.; Slayton, R. B.
title: Evaluation of Different Types of Face Masks to Limit the Spread of SARS CoV 2, A Modeling Study
date: 2021-04-27
journal: nan
DOI: 10.1101/2021.04.21.21255889
sha: 900d065a361d65e6aa830b1f6c1148c62bb94035
doc_id: 1019190
cord_uid: hbiopq2a

We updated a published mathematical model of SARS-CoV-2 transmission with laboratory-derived source and wearer protection efficacy estimates for a variety of face masks to estimate their impact on COVID-19 incidence and related mortality in the United States. When used at already-observed population rates of 80% for those [≥]65 years and 60% for those <65 years, face masks are associated with 69% (cloth) to 78% (medical procedure mask) reductions in cumulative COVID-19 infections and 82% (cloth) to 87% (medical procedure mask) reductions in related deaths over a 6 month timeline in the model. If cloth or medical procedure masks' source control and wearer protection efficacies are boosted about 30% each to 84% and 60% by cloth over medical procedure masking, fitters, or braces, the COVID-19 basic reproductive number of 2.5 could decrease to an effective reproductive number [≤] 1.0, and from 4.0 to {approx} 1.6 for the B.1.1.7 variant.

measured face mask efficacy parameters for a variety of specific types of masks and for efficacy 67 estimates that can act as benchmarks for evaluating these products [20] .

Methods:

We adapted the transmission model (used for studying resource allocation of masks) of Worby

and Chang (2020) for face mask adoption in a hypothetical population by expanding it to the 72 age-stratified social contact patterns characteristic of the demographic profile of the United

States. The underlying structure of this compartmental model is described in Worby and Chang

[20], which we briefly summarize. Individuals are classified according to their disease status and 75 whether or not they wear a mask in public. The model is further stratified by age in 5-year age 76 bands. People contact each other (defined as either direct physical contact, e.g. through a 77 handshake or a kiss, or a proximal, two-way conversation of 3 or more words) at age-specific 78 daily rates estimated for the United States, as described by Mossong et al. and Prem et al. [21, 79 22 ]. Vaccination is not explicitly part of the model and has not been included in this study.

A schematic of the compartmental model is shown in Figure 1 . Susceptible individuals who are 82 infected move into an exposed compartment and thereafter into a pre-symptomatic compartment.

Subsequently, a pre-specified proportion of these individuals moves into an asymptomatic state, This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 27, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 continue to mask thereafter. Similarly, a fraction of symptomatic cases is assumed to know they 90 have COVID-19, and these individuals put on a mask at the same adoption level as detected in 91 asymptomatic cases. Symptomatic persons and detected, asymptomatic persons who wear a 92 mask also change their contact rates reflective of some degree of isolation/quarantine. We do not 93 include specific compartments modeling quarantine per se, but rather we reduce contact rates 94 which accomplishes the same purpose and maintains simplicity of compartmental structure while 95 allowing a degree of mixing that might be anticipated among a fraction of infected individuals 96 who are not strictly isolating themselves. We also assumed a fraction of the general population 97 adopts mask usage at the outset and continues usage regardless of infection status. Other than the 98 aforementioned masked cases, we assumed that contact rates among age groups remain the same 99 when people wear a mask. A basic reproduction number (R0) of 2.5 was assumed in the absence 100 of any mask use, consistent with CDC's pandemic planning scenarios [23] . We also explored the 

Masks were modeled to reduce transmission via two different mechanisms: source control 108 efficacy, whereby mask wearing by an infectious person reduces their likelihood of transmitting 109 SARS-CoV-2; and wearer protection efficacy, whereby masks protect a susceptible person from 110 becoming infected when exposed to an infectious person. We examined adoption of various 111 kinds of masks (e.g., cloth, medical procedure, N95 respirators) specifically incorporating 112 for use under a CC0 license. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 27, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 estimates from a recent study of source control efficacy [14] . A range of values of hypothetical 113 wearer protection efficacy was assumed for each kind of mask. Although it has generally been 114 found that wearer protectiveness coefficients are approximately half the source control values 115 [13, 25, 26] , wearer protection efficacy was allowed to vary in the plot because it could be 116 greatly affected by how the mask is worn, maintained, and used. Characteristics of each mask 117 when worn according to manufacturers' specifications can be found in Lindsley et al. and are 118 shown in Table 1 [14]. We do not address the issue of mask and respirator use in healthcare 119 settings in this paper, as there is substantial public health guidance regarding the use of personal 120 protective equipment in healthcare settings [27] . (source control efficacy and wearer protection efficacy both 0%, equivalent to no mask wearing 129 in the population) these increase in 5% increments to the right top corner (source control efficacy 130 and wearer protection efficacy both 100%). For example, to obtain at least a 50% reduction in 131 cumulative infections, source control would need to be at least 55% efficacious in limiting This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 27, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 Even with the source control and wearer protection efficacy for the types of mask that most 136 wearers are likely to use, such as medical procedure or cloth masks and gaiters (see Table 1 ), 137 substantial reductions in case load and death can be achieved with general population use at 138 stated levels. Even at lower levels of use, reductions are estimated to be substantial As source 139 control and wearer protection efficacy approach 100% for the masks, relative reduction in 140 infections also approaches 100%, even though mask adherence is far from 100%, because 141 transmission dips below the epidemic threshold (i.e. an effective reproduction number < 1). Our 142 simulations project that a 70% reduction in cumulative infections, relative to zero mask usage, 143 could be achieved with hypothetical combinations of wearer protection and source control 144 efficacies, respectively, of (0%, 65%), (25%, 50%), (40%, 35%), (50%, 25%), among many and that mask use among persons <65 years old is 70% that of persons ≥65 years old. Mask 149 wearing rates for detected and infected people are fixed at 90% for those ≥65 years old, and 70% 150 for those who are younger. Based on the model, if 25% of the general population ≥65 years old 151 puts on a mask, cumulative cases after 6 months are reduced by 23% (N95), 14% (medical 152 procedure), 12% (cloth), 12% (gaiter), and 9% (bandana). If mask adoption is 50% for the 153 general population ≥65 years old, projected reductions in cases are 57% (N95), 32% (medical 154 procedure), 28% (cloth), 28% (gaiter), and 20% (bandana). If mask adoption is 75% for ≥65 155 years old, projected reductions in cases are 95% (N95), 65% (medical procedure), 55% (cloth), 156 54% (gaiter), and 35% (bandana). Note that even with 0% mask use for the susceptible population (horizontal axis), , there is still a small measure of infection control because of mask 158 adoption among detected infected people.

We estimated the incidence rate ratios (IRR) for new infections among mask wearers relative to 160 non-mask wearers over the course of 6 months, for different types of mask (Table 2 ). These This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 27, 2021. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 27, 2021. ; https://doi.org/10.1101/2021.04.21.21255889 doi: medRxiv preprint widespread adoption can mitigate transmission at the population level. Furthermore, if the most 204 common types of face mask -cloth and medical procedure masks -can be enhanced with more 205 recent recommendations to improve fit around the nose and mouth, such as braces, elastic fitters, 206 or even double masking, those substantial reductions can be improved upon. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 27, 2021. changes in behavior were modeled, this would add another favorable non-linear term to the 226 impact of mask wearing.

The pandemic literature does contain a minority of reports that do not confirm the efficacy of This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 27, 2021. 

The source data for mask efficacy used in these models were derived from controlled laboratory This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. sub-population, maintenance and proper use, and many other time-varying characteristics. This 273 may result in over-estimation of the impact of face masks on the pandemic. If so, even higher 274 mask uptake would be necessary to achieve substantial reductions in cases than is indicated here.

Although the post-holiday 2020-2021 surge in cases seems large given a fairly high rate of mask This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 27, 2021. 

Transmission of SARS-CoV-2 is modeled by a system of ordinary differential equations (ODE) 311 and compartments corresponding to age, disease status, and mask-wearing status. Compartments 312 comprise susceptible (S), exposed (E), pre-symptomatic (P), asymptomatic and undetected (Au), This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 27, 2021. ; https://doi.org/10.1101/2021.04.21.21255889 doi: medRxiv preprint population is N = S + E + P + Au + Ad + I + R. Initially, N = 100,000. Each of these compartments 315 is further stratified by age (16 age groups from the POLYMOD study) and mask-wearing status 316 (yes/no). Thus, each disease compartment is represented by a 16 × 2 matrix, with entries 317 corresponding to the number of individuals of that particular disease status in age group i = 318 1,…,16 and with mask status j = 0 (no mask), 1 (mask). In matrix form, the ODE system is: 

Compartment durations are specified by a rate νJ , where J is the compartment. Average duration 327 in a compartment is 1/νJ. These rates model the durations of days exposed (2 days), pre-328 symptomatic (4 days), asymptomatic (9 days), and symptomatic (9 days). Relative infectiousness 329 of pre-symptomatic and asymptomatic persons compared to symptomatic persons is prel inf = 0.75.

Detection probability of an asymptomatic case is pdetect = 0.05 and the proportion of 331 for use under a CC0 license. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. where m = 16 is the number of POLYMOD age groups corresponding to 5-year age bands 356 ranging from younger than 5 years old to 70-75 years old, with the oldest age group comprising 357 persons 75 years and older. The FoI is further stratified in the ODEs above depending on mask 358 status. This is implemented by the 2 × 2 matrix appearing in the differential equations for S and 359 E. This matrix governs reductions in the FoI according to source control efficacy (sce, or s for 360 brevity) and wearer protection efficiency (wpe, or w) conferred by the mask type. These combine 361 in four ways depending on the mask status of the infector and infectee (e.g., 1 -wpe and 1 − sce 362 multiply together in the case of transmission by mask wearers to mask wearers). We further 363 assume that symptomatic and detected, asymptomatic people who wear a mask have a lower, 364 daily rate of contact. As contact rates in compartmental models apply to susceptible, not 365 infectious, individuals, we model this as a reduction in infectiousness by a proportion r for both 366 symptomatic and detected, asymptomatic mask-wearers. Specifically, if subscript i indexes age 367 group and superscripts 'none' and 'mask' denote no mask and mask wearing, respectively, This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 27, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 where K none = I none + prel inf (P none + Ad none + Au none ) and 373 K mask = r I mask + prel inf (P mask + r Ad mask + Au mask ).

The age-specific vector pinf mask use (in the set of 7 ODEs specified at the beginning of this 375 supplement) specifies the proportion of symptomatic and detected asymptomatic people who don 376 a mask upon learning they are infectious. The corresponding proportion for symptomatic 377 individuals is pknow × pinf mask use. The 2 × 2 matrix appearing in the differential equations for Ad 378 and I governs the adoption of masks by asymptomatic individuals when they are detected (the 379 first column corresponds to no mask, the second to mask wearing). In simulations, we assumed 380 that individuals aged 65 years and older adopted masks at one proportion and younger than 65 381 years at another, lower, proportion (but this can be changed by the user). Expanding the matrix 

To seed the epidemic, we arbitrarily assumed that there were 10 detected, asymptomatic non- This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 27, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 The FoI was calibrated to yield a basic reproduction number R0 = 2.5 for the sub-model without 

Matrices F and V are of dimension 160 × 160 (2 mask statuses × 16 age groups × 5 relevant 408 compartment types). However, as new infections only arise from the E compartments, via the 409 previously described FoI, matrix F is sparse. So too is V, as a lot of its sub-blocks are zero or 410 diagonal matrices. Hence, we can construct these matrices in block form. We use the Kronecker 411 product of matrices, which we denote by ⊗.

The DFE depends on the initial age-specific proportions, psusc mask use, of the general, susceptible This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 27, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 respectively. These are multiplied by the hypothetical total population size N = 100,000 to obtain 416 numbers in each stratum.

Vectorizing the 16 × 2 matrices in the ODEs by stacking columns into a single 32 × 1 column 418 vector, we have the following constituent matrices for calculating R0:

For brevity, pr.i. denotes prel inf above, pACS is the ACS population age distribution, ps.m.u. denotes 421 psusc mask use above, w denotes WPE, s denotes SCE, 1n is the n×1 vector of 1's, and · represents 422 pointwise multiplication by column. Matrix M is the POLYMOD-derived contact matrix This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 27, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 The matrix F is given by F = qF1, where q is the calibration parameter representing the 434 probability of symptomatic infectious persons infecting susceptible persons upon contact 435 between them.

Matrix V may also be expressed in block form as:

where each block is a 32 × 32 matrix. Theory guarantees V is invertible. As with F, the order of 440 the component types in block rows and columns here is E, P, Ad, Au, I. The nonzero blocks are as 441 follows, with parameter notation as given earlier, and In denoting the n × n identity matrix:

Blocks VXX on the leading diagonal correspond to outflows from compartment type X. Off-444 diagonal blocks VXY correspond to inflows from compartment type Y to compartment type X. The This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 27, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 R0 = ρ(F V −1 ) = q × ρ(F1V −1 ).

Setting baseline R0 = 2.5 (no mask use), we calibrate q = 2.5 ÷ ρ(F1V −1 ).

Computation of symptomatic and asymptomatic detection rates

The percentage of symptomatic and asymptomatic SARS-CoV-2 cases that are detected are not 452 established numbers, but they are suspected to be low given the general detection rate of 9.1% This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Ad, asymptomatic and undetected Au, symptomatic I, pink), recovered (R, gray), and died (D, 594 gray). Superscript 'n' denotes no mask, and 'm' denotes mask.

for use under a CC0 license.

This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. shown on the horizontal and vertical axes. This analysis assumes 90% and 70% mask use rates 613 for infectious and detected persons older and younger than 65 years of age, respectively, and 614 80% and 60% among susceptible persons for the same age breakdown. Asymptomatic detection 615 and symptomatic awareness fractions are given in Table 1 . The baseline R0 in the absence of 616 mask use is assumed to be 2.5 in the left panel and 4.0 in the right panel. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 27, 2021. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 27, 2021. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 27, 2021. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 27, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 

Commentary: Masks-For-All for Covid-19 Not Based on Sound 465 Data

A cluster randomised trial of cloth masks compared with medical masks in 467 healthcare workers

Effectiveness of Surgical and Cotton Masks in Blocking SARS-CoV-2: A Controlled 469 Comparison in 4 Patients

Presumed Asymptomatic Carrier Transmission of COVID-19

Centers for Disease Control and Prevention. Considerations for Wearing Masks

Estimating the extent of asymptomatic COVID-19 and its potential for 476 community transmission: systematic review and meta-analysis

Probability of symptoms and critical disease after SARS-CoV-2 infection. arXiv

Prevalence of Asymptomatic SARS-CoV-2 Infection : A Narrative 479 Review

SARS-CoV-2 Transmission From People Without COVID-19 Symptoms. 481 JAMA Network Open

Mathematical assessment of the impact of non-pharmaceutical 483 interventions on curtailing the 2019 novel Coronavirus

To mask or not to mask: Modeling the potential for face mask use by the 485 general public to curtail the COVID-19 pandemic

Factors Associated with Cloth Face Covering Use Among Adults During the 487 COVID-19 Pandemic -United States

Aerosol Filtration Efficiency of Common Fabrics Used in Respiratory Cloth 490 Masks

Efficacy of face masks, neck gaiters and face shields for reducing the 492 expulsion of simulated cough-generated aerosols

SARS-CoV-2 Infections and Serologic Responses from a Sample of U.S. Navy 495 Service Members -USS Theodore Roosevelt

Absence of Apparent Transmission of SARS-CoV-2 from Two Stylists After 498 Exposure at a Hair Salon with a Universal Face Covering Policy

COVID-19: in the footsteps of Ernest Shackleton

Community Use Of Face Masks And COVID-19: Evidence From A Natural 503 Experiment Of State Mandates In The US. Health Aff (Millwood)

Effectiveness of Mask Wearing to Control Community Spread of 505 SARS-CoV-2

Face mask use in the general population and optimal resource 507 allocation during the COVID-19 pandemic

Projecting social contact matrices in 152 countries using contact 509 surveys and demographic data

Social contacts and mixing patterns relevant to the spread of infectious 511 diseases. PLoS medicine

Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking 516 epidemiological and genetic data

Surgical Mask Partition Reduces the Risk of Noncontact Transmission in a 518

Golden Syrian Hamster Model for Coronavirus Disease 2019 (COVID-19)

Effectiveness of Face Masks in Preventing Airborne Transmission of SARS-CoV-2. 521 mSphere, 2020. 5(5). 522 27. Centers for Disease Control and Prevention. Interim Infection Prevention and Control 523 Recommendations for Healthcare Personnel During the Coronavirus Disease

Available from: Interim Infection Prevention and Control 525 Recommendations for Healthcare Personnel During the Coronavirus Disease 2019 (COVID-19) 526 Pandemic

Theory-based Behavioral Predictors of Self-reported Use of Face Coverings in 528 Public Settings during the COVID-19 Pandemic in the United States

Uniting Infectious Disease and Physical Science Principles on the 530 Importance of Face Masks for COVID-19

Strategies to minimize SARS-CoV-2 transmission in classroom settings: 532 Combined impacts of ventilation and mask effective filtration efficiency

Maximizing Fit for Cloth and Medical Procedure Masks to Improve 535 Performance and Reduce SARS-CoV-2 Transmission and Exposure, 2021. MMWR Morb Mortal 536 Wkly Rep

Facial Masking for Covid-19 -Potential for "Variolation" as We 538 Await a Vaccine

COVID-19 seropositivity and asymptomatic rates in healthcare workers are 540 associated with job function and masking

Effectiveness of Adding a Mask Recommendation to Other Public Health 542 Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers : A Randomized Controlled 543 Trial

The Role of Masks in Mitigating the SARS-CoV-2 545 Pandemic: Another Piece of the Puzzle

Contamination and washing of cloth masks and risk of infection among 548 hospital health workers in Vietnam: a post hoc analysis of a randomised controlled trial

Trends in County-Level COVID-19 Incidence in Counties With and Without 551 a Mask Mandate -Kansas

COVID-19 Mitigation Behaviors by Age Group -United States

Evaluation of Cloth Masks and Modified Procedure Masks as Personal 556 Protective Equipment for the Public During the COVID-19 Pandemic

Quantitative Method for Comparative Assessment of Particle Removal 559 Efficiency of Fabric Masks as Alternatives to Standard Surgical Masks for PPE. Matter

data.census.gov

A language and environment for statistical computing

Solving Differential Equations in R: Package deSolve